Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes have it: Peninsula biotech focuses on glaucoma, more in big test © 2025 ...

Notice of the Cambridge biotech's layoffs came less than two weeks after Sage announced it would be acquired by ...

The opportunities I had as an aspiring researcher are gone. The path to a better life for kids in Sacramento is slipping away ...

The startup aims to provide every life sciences expert with their team of intelligent agents, reducing response timelines for ...

Sachin Dear Sachin, Bachelor of Business Administration (BBA) will provide a solid foundation for understanding business ...

Catalent Biologics Madison, 726 Heartland Trail, is expanding, bringing a boost to Wisconsin’s growing biohealth sector, with ...

Significant experience and expertise in teaching in biochemistry, biotechnology, and at least one of: bioinformatics, molecular biology, cell biology, microbiology, or data science at university level ...

The bill would cut $1.1 trillion in health-care spending and result in 11.8 million people losing health coverage over the ...

A major new player in pediatric research is coming to Atlanta. Shriners Children’s announced Wednesday that it will build a ...

Stock futures pointed to further gains Thursday, building on the momentum from big tech stocks Wednesday which helped drive new records highs on the S&P 500 and Nasdaq. After data yesterday from ADP ...

AS the countdown begins for Prime Minister Narendra Modi’s arrival in Port of Spain, great optimism fills the air. This ...

US pharmaceutical companies will be forced to answer questions this week from lawmakers, who have been grilling them on their ...